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Pilsen, Czech Republic; Chicago, Illinois; and Syracuse, New York
Objectives This study sought to evaluate outcomes of same-day discharge (SDD) following percuta-
neous coronary intervention (PCI) versus overnight hospitalization (ON).
Background Although there are data on the safety and feasibility of SDD after PCI, ON continues to
be prevalent.
Methods The Cochrane search strategy was used to search the PubMed database, EMBASE, and the
Cochrane Library for relevant literature. Thirteen studies (5 randomized and 8 observational) of SDD
after uncomplicated PCI versus ON met inclusion criteria. Data were pooled using a random effects
model, and reported as odds ratios (OR) with their 95% conﬁdence intervals (CI). The primary out-
comes were incidence of total complications, major adverse cardiovascular events (MACE), and re-
hospitalization within 30 days after PCI.
Results A total of 13 studies, involving 111,830 patients were pooled. There was signiﬁcant variation in
the deﬁnition of outcomes across studies. For total complications, the strategy of SDD compared with
ON after PCI had an estimated OR of 1.20 (95% CI: 0.82 to 1.74) in randomized and 0.67 (95% CI: 0.27 to
1.66) in observational studies. Similar results were found for MACE (randomized, OR: 0.99, 95% CI: 0.45 to
2.18; observational, OR: 0.59, 95% CI: 0.06 to 5.57) and rehospitalizations (randomized, OR: 1.10, 95% CI:
0.70 to 1.74; observational, OR: 0.62, 95% CI: 0.10 to 3.98) at 30 days post PCI.
Conclusions There is considerable heterogeneity across published studies comparing SDD with ON.
This, coupled with the low event rate and wide corresponding CIs, suggest that an adequately pow-
ered multicenter randomized trial comparing SDD with ON would require a very large sample size
(17,000). Until such a trial is completed, SDD after uncomplicated PCI seems a reasonable ap-
proach in selected patients. (J Am Coll Cardiol Intv 2013;6:99–112) © 2013 by the American
College of Cardiology Foundation
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100Since its first inception over 3 decades ago, percutaneous
coronary intervention (PCI) has become the most com-
monly performed cardiac intervention worldwide, with over
50% performed in the United States. The rising number of
PCI procedures worldwide, combined with the escalating
cost of health care, has led to significant logistic and
financial constraints on healthcare facilities. Given the
increased emphasis on measures to decrease medical care
expenditure while upholding clinical efficacy and patient
safety, same-day discharge after PCI in selected patients
may lead to reduced healthcare costs and increased patient
satisfaction. Over the past decade, continuous refinements
See page 113
of PCI procedures with the advent of coronary stents,
miniaturization of PCI equipment, and the evolution of
adjuvant pharmacology have substantially increased the suc-
cess, improved short- and long-
term safety of this technique, and
reduced post-procedural length of
stay (1–4).
A number of observational
and a few randomized studies
have described the safety of
same-day discharge (SDD) in
selected groups of patients (5–
17), adding to several single-
center reports extending back to
the mid -90s, which suggested
the feasibility and safety of this
strategy (18–27). Individual re-
ports have also highlighted po-
tential financial savings with this
approach, primarily by avoiding
the cost of an overnight stay
(28–30). Despite this, the practice of SDD after elective,
uncomplicated PCI remains considerably variable world-
wide, ranging from near routine in some parts of Europe,
Asia, and Canada, to being rarely adopted in the United
States. Reasons for this are multifactorial, including con-
cerns about patient safety and short-term clinical outcomes,
in addition to a perceived lack of fiscal incentive due to the
current reimbursement structure of the United States
healthcare system.
Many of the studies comparing SDD with overnight stay
(ON) have shown no difference in the outcomes that were
measured. This is either because both strategies are clinically
equivalent, or because of Type II error. Pooling of data from
all the studies may provide a large enough sample size to
better evaluate whether SDD and ON are comparable
with respect to patient outcomes. Accordingly, we un-
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
CI  confidence interval
GPI  glycoprotein IIb/IIIa
inhibitor
MACE  major adverse
cardiovascular events
MI  myocardial infarction
ON  overnight
hospitalization
OR  odds ratios
PCI  percutaneous
coronary intervention
SDD  same-day dischargedertook a systematic review and comprehensive meta-analysis of all available data comparing SDD after PCI
with ON, to evaluate the impact of this strategy on
clinical outcomes.
Methods
Eligibility, search strategy, and data collection. We per-
formed this review and meta-analysis with standard proto-
cols recommended by the Preferred Reporting Items for
Systematic Reviews and Meta-analysis (PRISMA) (31) and
the Quality of Reporting of Meta-analyses (QUOROM)
groups (32) for randomized trials, and the Cochrane Col-
laboration and Meta-analyses of Observational Studies in
Epidemiology (MOOSE) group (33) for observational
studies. The medical literature databases were scrutinized
for reports of studies with SDD after PCI. We performed a
search of the PubMed database, EMBASE, and the Co-
chrane Library, using key words, such as “same-day,”
“same-day discharge,” “outpatient,” “day-case,” “day-care,”
and “short stay” [AND] “PCI,” “PTCA,” “angioplasty,” and
“coronary angioplasty” (last update: 15 April 2011). There
was no date or language restriction for our selection of
publication. References of selected studies and all abstracts
from international cardiology meeting programs (American
College of Cardiology, American Heart Association, Euro-
pean Society of Cardiology, Transcatheter Cardiovascular
Therapeutics, and Euro-PCR) were searched for relevant data.
For the purpose of this review and meta-analysis, inclu-
sion criteria for studies were: 1) both randomized controlled
trials and observational studies comparing SDD and ON
following PCI; with 2) clinical and outcome data for up to
30 days following the index PCI procedure available for
both SDD and ON groups separately; and 3) intent-to-treat
or protocol-driven analysis. Exclusion criteria were: 1) studies
reporting only in abstract format or conference presentation
with no access to full data or manuscript; 2) studies reporting only
outcome data on SDD patients, with no ON group as a compar-
ator; 3) studies reporting on chronology of events but patients kept
hospitalized overnight; and 4) studies with mixed outcome data
between diagnostic and interventional procedures, or mixed out-
come data for both the SDD and ON groups, with no possibility
of separating individual outcomes. When study results were
reported in abstract format and subsequently in a full paper, only
results from the published manuscript were considered. Three
evaluators (E.A., O.F.B., and O.C.) performed literature searches,
and 2 (E.A. and O.F.B.) individually reviewed relevant articles,
and extracted data independently. Discrepancies between datasets
were resolved by consensus, if necessary after contact with authors.
Classiﬁcation of studies and outcome deﬁnitions. We clas-
sified the studies on the basis of randomized or observa-
tional design. The primary outcomes for this study-level
meta-analysis were the incidence of total complications,
major adverse cardiovascular events (MACE), and rehospi-
talization within 30 days following PCI.
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101The definitions of complications were study specific
(Table 1). Overall, it represents a summation of both cardiac
and noncardiac complications, encompassing access site,
bleeding and vascular complications, need for blood trans-
fusion, and cerebrovascular events. MACE was defined as
death, myocardial infarction (MI), or repeat revasculariza-
tion. The definition of MI was as per the study author’s
definition, and most commonly defined using both typical
symptoms, electrocardiogram, and enzymatic criteria (crea-
tine kinase-MB, troponin, or both). Repeat revasculariza-
tion was defined as the need for repeat PCI or coronary
artery bypass grafting. Rehospitalization was defined as
repeat hospital admission within 30 days of intervention for
any reason related to the index procedure.
Bleeding complications. There was no standardized defini-
ion for bleeding across all studies included herein, and the
otal number of bleeding events was taken directly from
apers, as defined by the authors. The largest randomized
tudy (Bertrand et al. [12]) in this analysis offered a
tandardized definition according to REPLACE-2 (Ran-
omized Evaluation in PCI Linking Angiomax to Reduced
linical Events) criteria for major bleeding and used this as
component of the study’s 7-event primary endpoint.
thers defined this as major bleeding requiring blood
ransfusion, or hemoglobin drop of 2 g/dl.
Vascular complications. The definition covered a wide spec-
rum of access site complications commonly encountered in
linical practice, such as arteriovenous fistula, pseudoaneu-
Table 1. Definition of Complications and MACE per Study Included in Meta
First Author, Year (Ref. #) Study Design* Number of Centers Popu
Knopf et al., 1999 (5) 1 1
Carere et al., 2000 (6) 1 1
Koch et al., 2000 (7) 0 1
Slagboom et al., 2001 (8) 0 1
Dalby et al., 2003 (9) 0 1
Yee et al., 2004 (10) 0 1
Slagboom et al., 2005 (11) 0 1
Bertrand et al., 2006 (12) 1 1
Heyde et al., 2007 (13) 1 1
Khater et al., 2007 (14) 0 1
Chung et al., 2010 (15) 0 1
Rao et al., 2011 (16) 0 903
Falcone et al., 2011 (17) 1 1
Significant heterogeneity of the definition of outcomes and complications was noted between stuAV arteriovenous; MACEmajor adverse cardiovascular events; MImyocardial infarction; TVR taysm, any complication requiring surgery, radial artery
cclusion, local infection requiring antibiotics, moderate–
evere hematoma, and major bleeding.
Data synthesis and statistical analysis. Information on study
esign, sample size, population demographic characteristics,
oronary angiographic characteristics, access site for PCI,
rocedural adjuvant pharmacotherapy, procedural success
ate, outcome, and follow-up data were extracted and
ntered into a data sheet using a standardized protocol. The
bsolute numbers of events for each outcome of interest in
very study were extracted for the SDD and ON groups,
nd entered into a statistical software program (the Co-
hrane Collaboration’s Review Manager [RevMan], version
.1.20, Nordic Cochrane Centre, Copenhagen, Denmark),
hich was used to synthesize the results. Differences in
tudy characteristics, inclusion and exclusion criteria, pro-
edural variables, and practice patterns mean that the true
ffect from each study is likely to vary, and a fixed-effects
eta-analysis model would not account for this between-
tudy variation. We therefore used the DerSimonian and
aird random effects model, with weights calculated using
he Mantel-Haenszel method to better account for the
ifferences between studies. Dichotomous outcomes data
ere measured and reported as odds ratio (OR), with their
5% confidence intervals (CIs) for randomized and obser-
ational studies. We examined heterogeneity across studies
ith the Cochran’s Q statistic (based on the pooled OR)
nd the I2 statistic test. An I2 value of25% was considered
sis
Total N Definition of Complications
90 Death, MI, urgent revascularization, acute vessel dissection/occlusion,
cardiac arrhythmia, AV ﬁstula with repair, recurrent chest pain
00 Need for vascular surgery, external bleeding, hematoma,
blood transfusion
15 Death, MI, urgent revascularization during hospitalization, pericardial
effusion, or any complication requiring prolonged hospitalization
59 Cardiac death, MI, urgent revascularization, MI, UA,
major access site complication, major bleeding
70 Death, MI, TVR
75 MACE, vascular access site complications
44 Cardiac death, urgent revascularization, MI, rehospitalization,
major access site complications and bleeding
05 Death, MI, urgent revascularization, major bleeding,
repeat hospitalization, severe thrombocytopenia, and
access site complications
00 Cardiac death, MI, stroke, urgent revascularization,
access site complications
50 Death, MI, urgent revascularization, access site complications
60 Death, MI, urgent revascularization, stroke, bleeding, transfusion,
rehospitalization, access site complication
18 Death, rehospitalization, bleeding, access site complications
44 Death, MI, stroke, rehospitalization, access site complications
 observational study; 1 randomized.-Analy
lation
1
1,0
1
6
1,0
8
1
6
107,0
dies *0rget vessel revascularization; UA unstable angina.
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102low heterogeneity, 25% to 50% moderate, and a value
50% was considered substantial heterogeneity. Funnel
plots were constructed and inspected visually for evidence
of publication bias (data not shown). The weight of each
trial on the overall results of meta-analysis outcome was
calculated as a percentage of the number of patients in
492 Potentially relevant titles and abstracts identified
59 Potentially relevant articles retrieved for full-text inspection
19 Potentially appropriate articles identified to be included in m
13 RCT and observational studies with usable information by
in meta-analysis: 
5 RCT
8 Observational studies
14 Potentially appropriate articles to be included in meta-anal
2 Manually identified references:
1 Conference presentation
1 Letter to editor
Figure 1. Flow Chart of Search Strategy and Studies Selection
PRISMA ﬂow diagram showing literature search strategy, and selection process
Early Discharge After Transradial Stenting of Coronary Arteries study; ON  ov
transluminal coronary angioplasty; RCT  randomized controlled trials; SCAI 
charge; STEMI  ST-segment elevation myocardial infarction;that given trial over the total number included in each
outcome analysis.
A sensitivity analysis was performed according to study
design (randomized and observational) and population size
to determine the effect of the largest study on the outcome
of the meta-analysis.
rticles excluded after detailed review:
1 Case report
3 Editorials
1 Review articles
1 Consensus document (SCAI)
1 Survey for SCAI on usage of outpatient PCI
1 Comment (Harvard Letter)
1 Conference presentation, no manuscript (contacted authors)
2 Abstracts only with population overlap with other identified studies
3 Scientific letter/ letter to the editor with reports of outcome of SDD
patients only
12 Single center reports with outcome data for SDD only and no ON 
comparator
2 Single center studies, reporting chronology of events but patients 
actually kept ON
1 Satisfaction survey and population overlap with identified report
3 Single center reports with no comparator, + population overlap
1 Single center report on outcomes in patients < and > 75 yrs and 
population overlap
1 Self-behaviour after day-case PCI
2 Early & Late FU of patients excluded from EASY + EASY 1-yr FU
3 Cost-effectiveness analysis of SDD
2 Predictors of re-admission at 30 days post PCI/unplanned 
admission after diagnostic angiography
alysis
Excluded from meta-analysis as no 30-day outcome data 
e included 
xcluded after review of title, abstract, type of article
402 Irrelevant
15 Peripheral/Carotid/Renal angioplasty
2 Transradial peripheral vascular interventions 
3 Hybrid same-day PCI and CABG
10 Primary PCI for STEMI/ Same day transfer to and from centers
1 SDD after Radiofrequency Ablation
cluded after further review
1 Same-day transfer back to referring hospital after PCI for NSTEMI 
with 24 Hr. FU only
2 Single center reports with short stay post PTCA, kept overnight
1 Report in Italian with mixed FU data on both diagnostic 
angiography and SDD-PCI
1 Single center report with mixed outcome data for ON and SDD-
PCI at 30 days
clusion in meta-analysis. CABG  coronary artery bypass grafting; EASY 
t stay; PCI  percutaneous coronary intervention; PTCA  percutaneous
ty for Cardiovascular Angiography and Interventions; SDD  same-day dis-42 A
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103Results
A total of 13 studies conducted between 1999 and 2011 were
included in the meta-analysis (Fig. 1). Five studies were
randomized trials, and 8 were observational studies. Twelve
studies were single-center (n  4,182 patients), and 1 was a
arge U.S. multicenter observational study (N  107,018
atients). Three studies were conducted in the United States, 3
n Canada, 5 in Europe, and 2 in Asia. Baseline characteristics
nd procedural data of study populations are shown in Table 2.
ur comprehensive review involved a total of 111,830 patients
2,039 enrolled in randomized trials, and 109,791 in observa-
ional studies), with 4,179 (3.7%) in the SDD, and 107,651
96.3%) in the ON group. The mean age for the entire
eta-analysis population was 62  4.9 years. Of these, 64%
ere men, 32% were diabetic, 82% had systemic hypertension,
9% had dyslipidemia, 39% had prior PCI, and 23% had prior
oronary artery bypass grafting. Patients in randomized
rials (n  2,039) were slightly younger (60  2 years vs.
3  6 years), and more often men (79% vs. 64.5%) than
Figure 2. Selection Process for Eligibility for SDD in Randomized Trials
Flow diagram illustrating the selection process for same-day discharge (SDD) in ra
combines clinical, procedural, and periprocedural criteria, and ﬁnal triage based on
domized study design, approximately 80% to 88% of patients initially assigned fon observational studies. 3Twelve studies (n  110,825) examined elective PCI
n stable angina, but a small proportion also included
nstable angina (Braunwald Class 1 and 2). A single
andomized trial (EASY [Early Discharge After Trans-
adial Stenting of Coronary Arteries]) with 1,005 pa-
ients, examined SDD after PCI in unstable angina and
cute coronary syndrome (ACS) with elevated troponin,
hich represented 25% of study population (12). Khater
t al. (14) also included low-intermediate risk ACS
atients (using Thrombolysis In Myocardial Infarction
isk scoring) in their single-center study of 150 patients.
total of 96% were treated via the femoral approach,
hereas transradial access was used in 3%, and a minority
f 0.36% had brachial access. When the large observa-
ional study of Rao et al. (16) was excluded, radial access
as used in 45% of the remaining population, reflecting
he current lower utilization of radial access in the United
tates compared with Europe, Asia, and Canada. Mul-
ivessel PCI was performed in 16% of patients, whereas
ized trials included in the meta-analysis. This systematic selection process usually
al stability and other factors (e.g., social) during the observation period. In a ran-
are discharged. NR  not reported; other abbreviations as in Figure 1.ndom
clinic
r SDD7% had angiographic Type B or C lesions.
Table 2. Baseline Characteristics of Included Studies
Variable
Knopf
1999 (5)
Carere
2000 (6)
Koch
2000 (7)
Slagboom
2001 (8)
Dalby
2003 (9)
Yee 2004
(10)
Slagboom
2005 (11)
Bertrand 2006
EASY Study (12)
Heyde 2007
EPOS
Study (13)
Khater
2007 (14)
Chung
2010 (15)
Rao
2011 (16)
Falcone 2011
ABDCD-PCI (17)
Demographics
Patients, total 90 100 1,015 159 70 75 644 1,005 800 150 660 107,018 44
SDD 43 50 922 106 51 25 375 504 403 124 214 1,339 23
ON 47 50 87 53 19 50 269 501 397 26 446 105,679 21
Men, total 57 83 745 124 57 65 490 790 648 123 562 67,392 31
SDD 26 44 — 85 41 21 290 395 327 99 181 863 15
ON 31 39 — 39 16 44 200 395 321 24 381 66,529 16
Age, yrs 58 — 60 — 65.1 — 60 60.5 62 58 — 73 —
SDD 57 62 — 63 65.3 55.9 60 60 62.1 58 59.7 73 60.6
ON 59 59 — 62 64.6 56.5 60 61 61.1 57 61.7 73 57.0
DM, total 18 — 130 21 11 13 85 165 121 60 180 35,627 20
SDD 7 — — 12 9 4 54 83 65 50 60 443 11
ON 11 — — 9 2 9 31 82 56 10 120 35,184 9
HTn, total 50 — 418 46 39 32 238 539 320 66 388 89,223 40
SDD 22 — — 25 26 9 139 263 165 56 128 1,075 20
ON 28 — — 21 13 23 99 276 155 10 260 8,848 20
Prior MI total 28 — 516 62 18 — 227 443 285 34 265 — 11
SDD 14 — — 38 13 — 129 219 130 31 107 — 4
ONS 14 — — 24 5 — 98 224 155 3 158 — 7
Prior CABG total 12 — 57 18 14 — 54 — 28 — — 25,119 —
SDD 5 — — 12 10 — 37 — 13 — — 303 —
ON 7 — — 6 4 — 17 — 15 — — 24,816 —
Prior PCI total 47 — 263 51 14 — 155 200 168 — — 42,988 20
SDD 22 — — 34 10 — 89 107 84 — — 578 10
ONS 25 — — 17 4 — 66 93 84 — — 42,410 10
Continued on the next page
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Table 2. Continued
Variable
Knopf
1999 (5)
Carere
2000 (6)
Koch
2000 (7)
Slagboom
2001 (8)
Dalby
2003 (9)
Yee
2004 (10)
Slagboom
2005 (11)
Bertrand 2006
EASY Study (12)
Heyde 2007
EPOS Study (13)
Khater
2007 (14)
Chung
2010 (15)
Rao
2011 (16)
Falcone 2011
ABDCD-PCI (17)
Procedural data
Brachial access, total 0 0 0 0 0 0 0 0 0 0 0 405 0
SDD 0 0 0 0 0 0 0 0 0 0 0 5 0
ON 0 0 0 0 0 0 0 0 0 0 0 400 0
Femoral access, total 90 100 1,015 0 70 75 322 0 800 150 0 104,552 44
SDD 47 50 922 0 51 25 177 0 403 126 0 1,290 23
ON 43 50 87 0 19 50 145 0 397 24 0 103,262 21
Radial access, total 0 0 0 159 0 0 322 1,005 0 0 660 1,680 0
SDD 0 0 0 106 0 0 198 504 0 0 214 42 0
ON 0 0 0 53 0 0 124 501 0 0 446 1,638 0
Sheath size, F 8 8 6 6 6–8 6–7 6 5–6 5–6 6–8 5–8 — —
SDD 8 8 6 6 6–8 6–7 6 5–6 5–6 6–8 5–6 in 98.6 — —
ON 8 8 6 6 6–8 6–7 6 5–6 5–6 6–8 5–6 in
89.9%
— —
Type B2/C lesion, total — — 951 27 43 45 184 641 927 118 481 37,882 0
SDD — — — 14 27 13 67 321 453 94 128 442 0
ON — — — 13 16 32 117 320 474 24 353 37,440 0
MV PCI total 11 — 117 0 0 0 — 317 141 43 37 17,474 —
SDD 2 — — 0 0 0 — 149 71 34 6 189 —
ON 9 — — 0 0 0 — 168 70 9 31 17,285 —
Lesions, total 106 — 1,510 180 82 — 814 — 1,240 — — — —
Procedural anticoagulant
Heparin, % 100 100 100 100 100 100 100 100 100 100 100 40.5 —
GPI, % 0 0 0 0 0 0 — 100 6.4 8.7 0 23.1 0
Bivalirudin, % 0 0 0 0 0 0 0 0 0 0 0 50.6 0
Hemostasis
VCD total 0 50 0 0 68 75 0 0 0 — 0 53,834 44
SDD 0 50 0 0 50 25 0 0 0 — 0 871 23
ON 0 0 0 0 18 50 0 0 0 — 0 52,963 21
Length of hospital stay post-PCI, h
SDD 8–10 11 4 4–6 6 10 4–6 4–6 — 10 4–6 — 3
ON 23 22 FM FM FM FM FM FM FM FM FM — FM
Summary of demographic characteristics of meta-analysis population, procedural data, and average hospital length of stay is shown.
CABG coronary artery bypass grafting; DM diabetes mellitus; FM following morning; GPI glycoprotein IIb/IIIa inhibitor; HTn hypertension; MImyocardial infarction; ON overnight stay; PCI percutaneous coronary intervention; SDD same-day
discharge; VCD vascular closure device.
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106In 4 of 5 randomized, and 7 of 8 observational studies,
the anticoagulant of choice in 100% of patients was unfrac-
Table 3. Summary of Selection Criteria for SDD in Meta-Analysis Studies
First Author,
Year (Ref. #)
Patients
Total N Pre-Procedural
Knopf et al., 1999 (5)
randomized
90 Age 80 yrs
Stable/unstable angina, or recent
MI 5 days
No illness requiring medical care
No communication barrier
Non–
No L
pr
oc
in
th
Carere et al., 2000 (6)
randomized
100 Elective or urgent PCI  stenting
(provided operator felt SDD
possible).
Creatinine 150 mol/L
BP  180/100
No PVD or pre-existing femoral
hematoma
NR
Koch et al., 2000 (7)
observational
1,015 Consecutive patients undergoing
elective PTCA.
No planned IABP; no acute MI or
UA class 3
Succ
w
No a
cr
Angi
pr
ex
Slagboom et al., 2001 (8)
observational
159 Stable/unstable angina (class 1
and 2)
No acute MI
Adequate collateral hand blood
supply
No non-PTCA reason to remain
hospitalized
Shea
Type
C
No e
ca
in
No d
oc
Dalby et al., 2003 (9)
observational
70 Elective PCI.
Noncomplex cases
No signiﬁcant comorbidities
Nonc
Succ
w
No p
Yee et al., 2004 (10)
observational
75 Elective PCI for stable angina,
Age 18–75 yrs
No bleeding disorder,
anticoagulation, systemic or
local infection (VCD)
No PVD
Clean
Singl


Shea
Slagboom et al., 2005 (11)
observational
644 Stable/unstable angina class
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randomized
1,005 Ad hoc PCI procedures
Age 18 yrs
No recent MI (72 h)
LVEF 30%
No condition precluding SDD
No intolerance to aspirin or
thienopyridines
INR ratio 2.0
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HDtionated heparin (UFH). In the EASY randomized trial, allpatients received abciximab (bolus only in SDD patients vs.
bolus plus a 12-h infusion in the ON group) in addition to
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Successful uncomplicated PTCA
Clinically stable patient
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hemostasis
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d hemodynamic
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Optimal PTCA result
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NR
oronary stenting by
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t vessel closure or
pse during PCI
After successful ad hoc stenting,
randomized to only abciximab
bolus
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107Study) randomized trial (13) and in 2 of the observational
studies, investigators permitted variable use of a glyco-
protein IIb/IIIa inhibitor (GPI). In the large observational
study of Rao et al. (16), 40.5% of patients received UFH,
50.6% bivalirudin, whereas 23.1% received a GPI.
Of the 2,039 patients in randomized trials, 1,023 (50.2%)
were assigned to SDD after PCI, and 1,016 (49.8%) to ON.
Of the 1,023 assigned to SDD, 851 (83%) were successfully
discharged home the same day of PCI, whereas 172 (17%)
developed an indication for extended observation, and
crossed over to an overnight stay (Fig. 2). Reasons for this
included procedural-related complications, such as major
Table 3. Continued
First Author,
Year (Ref. #)
Patients
Total N Pre-Procedural
Heyde et al., 2007 (13)
randomized
800 Patients scheduled to undergo
elective PCI eligible for
enrollment if they remained at
home before the procedure
and did not have an ACS,
No long-term systemic
anticoagulation
Use of G
No elec
There w
exclu
Khater et al., 2007 (14)
observational
150 Adults 18 yrs old
Creatinine 2 mg/dl
Diagnoses of stable angina or
low–intermediate risk ACS
using TIMI risk score.
Docume
mult
for P
Utilizati
the o
Chung et al., 2010 (15)
observational
660 Pts. referred for elective/ad hoc
TRA PCI
LVEF 30%
No CKD (creatinine 2.0 mg/dl)
No LMS
Uncomp
Rao et al., 2011 (16)
observational
107,018 107,018 pts 65 yrs undergoing
elective PCI procedures at 903
U.S. sites participating in the
CathPCI registry between
November 2004 and
December 2008
Exclusion: UA, NSTEMI, or STEMI;
emergency, urgent, or salvage
procedures; CPR en route to
the cath lab
Cardiogenic shock
Success
Falcone et al., 2011 (17)
randomized
44 Age 75 yrs
Type A or B lesion 2 h post PCI
No acute MI
INR 2, plt 100,000,
HCT 25%
No CKD
LVEF 30%
No othe
besid
used
PCI nati
No evid
Implant
No diss
durin
Femora
to VC
A 4-step selection process for SDD (clinical, procedural, post-procedural, and discharge or social) an
ACS acute coronary syndrome; BP blood pressure; CKD chronic kidney disease; CP ch
GC guiding catheter; GPI glycoprotein IIb/IIIa inhibitor; HCT hematocrit; HD hemodynam
anterior descending artery; LMS  left main stem; LV left ventricle/ventricular; LVEF  left ven
non–ST-segment elevation myocardial infarction; Pt  patient; PTCA  percutaneous translumina
myocardial infarction; SVG saphenous vein graft; TIMI Thrombolysis InMyocardial Infarction; TRAcoronary dissection not suitable for stenting, in-lab transientvessel closure with hemodynamic collapse, intracoronary
thrombus, pericardial effusion, procedural arrhythmia, wire
perforation, chest pain, or issues with the access site (e.g.,
hematoma, delayed hemostasis). Very few were due to social
reasons or to patient refusal after randomization.
Where reported, the average length of stay after PCI in
the majority of studies ranged between 4 and 11 h for SDD,
with 77% of patients sent home between 4 and 8 h
post-procedure, and 1 day for ON, with very few patients
kept longer for various clinical indications. Selection criteria
for SDD varied significantly between individual studies
(Table 3), with the majority agreeing on the following
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cedural Post-Procedural Discharge
-F
e of GPI
angiographic
riteria
Pts. who met inclusion criteria,
randomized to SDD after
decision to perform PCI, but
before the start of PCI
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ingle or
CAD amenable
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Not receiving GPI
No major complications or
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supervision and
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or SB occlusion
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; CPR cardiopulmonary resuscitation; CTO chronic total occlusion; ECG electrocardiogram;
odynamically; IABP intra-aortic balloon pump; INR international normalized ratio; LAD left
ejection fraction; MACE  major adverse cardiovascular events; NR  not reported; NSTEMI 
ry angioplasty; PVD  peripheral vascular disease; SB  side branch; STEMI  ST-segment elevation
dial access; UA unstable angina; VD vessel diameter; other abbreviations as in Tables 1 and 2.Pro
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108low–moderate risk ACS, successful uncomplicated PCI,
stable clinical condition post-PCI, and patients’ willing-
ness to go home with the ability to reach the emergency
department within a reasonable time (40 to 60 min), and
adequate social support.
In the randomized trials, the total number of complica-
tions in the SDD group was 67 of 1,023 (6.5%) versus 56 of
1,016 (5.5%) for the ON group (OR: 1.20, 95% CI: 0.82 to
1.74). The total number of complications reported in the
SDD group in the observational data were 148 of 3,156
(4.7%) versus 10,272 of 106,629 (9.6%) for the ON group,
(OR: 0.67, 95% CI: 0.27 to 1.66) (Fig. 3). To assess the
influence of the Rao et al. study (16) with the largest
population size, we performed a sensitivity analysis by
removing this study from the forest plot. For the remaining
pooled observational studies, total complications in the
SDD group was 19 of 1,817 (1.0%) versus 23 of 950 (2.4%)
in the ON group (OR: 0.4, 95% CI: 0.07 to 2.14). At 30
days, the incidence of MACE in the SDD versus the ON
group in randomized trials was 13 of 1,023 (1.3%) versus 13
of 1,016 (1.3%) (OR: 0.99, 95% CI: 0.45 to 2.18), and in
observational studies 10 of 1,817 (0.6%) versus 11 of 950
(1.2%) (OR: 0.59, 95% CI: 0.06 to 5.57) (Fig. 4). Finally,
Figure 3. Forest Plot of the Incidence of 30-Day Total Complications
Meta-analysis of pooled data from randomized and observational studies show
Haenszel (M-H) random effects model. Outcomes data were measured and rep
across studies denoted by the I2 statistic test. An I2 value of 25% was consid
substantial heterogeneity. The weight of each trial on the overall results of me
intervention.the incidence of rehospitalizations within 30 days after PCIbetween the SDD and ON groups in randomized trials was
41 of 1,023 (4.0%) versus 37 of 1,016 (3.6%) (OR: 1.10,
95% CI: 0.70 to 1.74) and in observational studies 131 of
1,645 (8.0%) versus 10,147 of 105,827 (9.6%) (OR: 0.62,
95% CI: 0.10 to 3.98), respectively (Fig. 5). When Rao et al.
(16) was excluded, the incidence of rehospitalization in
observational studies was 3 of 306 (1.0%) in the SDD versus
2 of 148 (1.4%) in the ON group (OR: 0.34, 95% CI: 0.01
to 22.57).
Discussion
In this systematic review and comprehensive meta-analysis,
we show that many carefully selected and risk-stratified
groups of patients undergoing elective or ad hoc PCI for
low–intermediate risk ACS have been managed successfully
with an SDD strategy. Still, due to the low event rate, the
significant variation in the definition of outcomes across
studies, and wide confidence intervals around the pooled
point estimates, a definitive resolution of a statistically
significant hazard or benefit to the SDD approach cannot be
determined based on the totality of presently available data.
With the advancement of operative techniques and sur-
e incidence of total complications at 30 days post PCI, using a Mantel-
as odds ratio (OR), with their 95% conﬁdence intervals (CI). Heterogeneity
ow heterogeneity, 25% to 50% moderate, and a value 50% was considered
lysis outcome is displayed as a percentage. PCI  percutaneous coronarying th
orted
ered l
ta-anagical equipment over the past few years, a number of
m effe
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109noncardiac disciplines have evaluated the benefits and safety
of SDD (34–36). This practice has also been extended to
selected vascular procedures performed under general anes-
thesia and to interventional peripheral, renal, and carotid
angioplasty (37). With significant accomplishments in
safety and success, PCI techniques have likewise progressed
to the point that SDD after PCI is not uncommon in many
countries, without reported issues of safety.
Hesitance in changing current practice could broadly be
attributed to 4 potential challenges. First, the biggest hurdle
seems to be the medicolegal concerns from the medical
community, hospitals, and care providers, which relate to
the safety of SDD. Second, there may be concerns on the
part of physicians, nurses, and hospitals that an SDD
strategy may not provide enough time to educate patients
about their underlying disease and/or their PCI procedure.
Third, there is a misconception that current payment
systems, such as in the United States, provide a disincentive
to hospitals and physicians to change practice and discharge
patients the same day as their procedure. Fourth, some
patients may be reluctant to accept an SDD strategy after
uncomplicated PCI.
Despite the spreading adoption of SDD after PCI prac-
tices worldwide, the present comprehensive systematic re-
view and meta-analysis of all available clinical data involving
111,830 patients cannot scientifically resolve the ultimate
Figure 4. Forest Plot of the Incidence of 30-Day Total MACE
Meta-analysis of pooled data from randomized and observational studies show
post-percutaneous coronary intervention (PCI), using a Mantel-Haenszel randoquestion: whether SDD after uncomplicated PCI in aselected subgroup of patients is as safe as or safer than ON.
To scientifically resolve this question, assuming similar
results for total complications as obtained in this meta-
analysis and a noninferiority design according to the Black-
welder equation, a large sample size would be required.
Indeed, if there is truly no difference between ON and SDD
strategies, then 17,812 patients would be required to be 90%
sure that the upper limit of a 1-sided 95% confidence
interval will exclude a difference in favor of the ON strategy
of more than 1%.
In this meta-analysis, and by definition, patients in
randomized trials who were discharged the same day as their
PCI had a similar risk profile to those hospitalized over-
night. In particular, no clinically important differences in
medical comorbidities, procedural characteristics, multives-
sel PCI, high-risk lesions, access site, or use of vascular
closure devices were observed between the 2 groups (Table
2). By contrast, patients in observational studies who were
discharged home the same day of their PCI were a highly
selected population as evaluated by the operators. Although
it is likely that individual centers have created their local
protocols for SDD after PCI, our review highlights the lack
of standardized selection criteria for this strategy and the
lack of standardized definitions of outcomes used across
studies. Existing recommendations in the Society for Car-
diovascular Angiography and Interventions statement (38)
e incidence of total major adverse cardiovascular events (MACE) at 30 days
cts model. Abbreviations as in Figure 3.ing th(endorsed by the American College of Cardiology) on SDD
in Fig
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110may be more conservative than what current “real-world”
practice may be (39). Central to many discussions over the
merits of SDD versus ON care is an assumption that more
hospitalization, although clearly more expensive, is also by
definition safer. No trials have attempted to look at the
hazard of hospitalization in this patient population, but a
recent systematic database review has suggested the risk
from an overnight stay in the hospital includes 0.4% of skin
ulcer formation, 3.4% suffering adverse drug reactions, and
11.1% of infection (40).
Complications after PCI include ischemic events, such as
periprocedural MI and acute stent thrombosis, as well as
bleeding and vascular complications. In the contemporary
PCI era, there are several strategies to minimize both types
of complications. Coronary stents have reduced the risk for
abrupt closure, and potent antiplatelet and anticoagulant
combinations reduce the risk for periprocedural MI. Ap-
propriate dosing antithrombotic medications, or the pre-
ferred use of radial access, can reduce bleeding and vascular
complications (41–43). Some observational studies suggest
that the use of femoral closure devices in selected patients
may also be associated with a reduction in vascular compli-
cations (44); however, the exact clinical benefit remains
controversial. Given the myriad options to optimize PCI
safety and efficacy, an SDD strategy may be a natural
evolution of post-procedural care. Key to the success of this
strategy, however, is judicious patient selection. Moreover,
Figure 5. Forest Plot of the Incidence of 30-Day Rehospitalization
Meta-analysis of pooled data from randomized and observational studies show
vention (PCI), using a Mantel-Haenszel random effects model. Abbreviations aspatient education regarding late complications that mayoccur after PCI is an integral part of an SDD program. A
multidisciplinary team approach of all healthcare providers
involved in patient pathways, as well as hospital adminis-
trators, is needed to build a successful SDD program.
Some investigators also reported patients’ preference for
and satisfaction with SDD strategy after PCI (13,45). It is
clear that patients’ education on the safety of outpatient PCI
in selected patients is pivotal in ensuring the success of such
a program. Because PCI is no longer considered a criterion
for inpatient admission by default, the reimbursement
scheme for elective PCI in the United States has shifted
towards Ambulatory Payment Classification billing, instead
of the Diagnosis-Related Group reimbursement system for
inpatient procedures (38). Furthermore, in 2010, the U.S.
Centers for Medicare & Medicaid Services extended its
Recovery Audit Contractor program to all 50 states, with
heightened scrutiny of hospital billing practices and inap-
propriate admissions related to procedures, which might
have a noticeable impact on shifting current PCI practice
toward shorter lengths of stay.
Study limitations. To the authors’ knowledge, this system-
atic review and meta-analysis represents the most current
and comprehensive analysis of available studies on SDD
after PCI. Some of the observational studies included in
this meta-analysis are of extremely small size, and the
influence of the largest multicenter study to date (Rao et
al. [16]) of 100,000 patients should be noted. An
e incidence of rehospitalization at 30 days post-percutaneous coronary inter-
ure 3.ing thinherent limitation of any meta-analysis is that of publi-
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111cation bias. Although we included all randomized studies
to date on this analysis, there was a large presence of
single-center observational data (both retrospective and
prospective). Other important issues such as patient
satisfaction, quality of life, and costs were not addressed
in those studies. They should be further studied in future
comparative studies.
Conclusions
Considerable heterogeneity exists across published studies
comparing SDD after PCI with ON, with significant
variation in the populations studied, as well as the definition
of outcomes. Despite a large sample size from pooling of
randomized and observational studies, the point estimates
for the OR between SDD and outcomes had wide CIs.
With current heterogeneity between studies and wide CIs,
an adequately powered multicenter randomized trial com-
paring SDD with ON would require a very large sample
size. Until such a trial is completed, SDD after uncompli-
cated PCI seems a reasonable approach in selected patients.
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